Loading institutional data...
Loading institutional data...
Held by 206 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $67.47 today, the market must believe free cash flow compounds -3.3%/yr for a decade (off $89M normalized FCF).
2-stage DCF · 0.01B shares · net debt $15M
mean 590.0% · volatility σ 1849% · implied rate exceeded in 4/9 yrs
Central path = implied -3.3%/yr growth; shaded band = ±1σ (1849%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $24M dividends + $0 buybacks = $24M returned on -$20M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Modest payoff on reinvested capital. Current ROIC on all capital: 16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $585000 covers the $0 due within a year 585000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-06-26 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~22.7% on $16M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 84.4 | 81.9 | 80.0 | 78.5 | 79.1 | 78.8 | 79.9 | 81.6 |
| Gross Profit | 15.6 | 18.1 | 20.0 | 21.5 | 20.9 | 21.2 | 20.1 | 18.4 |
| R&D | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 |
| SG&A | 3.4 | 4.3 | 4.3 | 4.3 | 3.9 | 4.5 | 4.5 | 3.6 |
| Operating Income | 6.3 | 6.7 | 8.9 | 9.9 | 9.1 | 9.0 | 8.0 | 7.7 |
| Income Tax | 1.9 | 1.5 | 2.1 | 2.3 | 2.1 | 2.3 | 1.8 | 1.7 |
| Net Income | 3.7 | 4.5 | 6.1 | 7.0 | 6.5 | 6.3 | 5.6 | 5.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on JBSS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.11B 100.0% | $1.07B 100.0% | $999.7M 100.0% | $955.9M 100.0% | $858.5M 100.0% | $880.1M 100.0% | $876.2M 100.0% | $888.9M 100.0% | $846.6M 100.0% | $952.1M 100.0% |
| Cost of Revenue | $903.8M 81.6% | $852.6M 79.9% | $788.1M 78.8% | $756.2M 79.1% | $673.5M 78.5% | $704.3M 80.0% | $717.9M 81.9% | $750.0M 84.4% | $704.7M 83.2% | $814.6M 85.6% |
| Cost of Products | — | — | — | — | — | — | — | — | $704.7M 83.2% | $814.6M 85.6% |
| Gross Profit | $203.5M 18.4% | $214.1M 20.1% | $211.6M 21.2% | $199.6M 20.9% | $185.0M 21.5% | $175.8M 20.0% | $158.3M 18.1% | $138.9M 15.6% | $141.9M 16.8% | $137.5M 14.4% |
| Research & Development | $3.5M 0.3% | $3.6M 0.3% | $3.4M 0.3% | $2.8M 0.3% | $2.0M 0.2% | $999K 0.1% | $892K 0.1% | $701K 0.1% | $658K 0.1% | $653K 0.1% |
| Selling, General & Admin | $39.8M 3.6% | $48.5M 4.5% | $44.6M 4.5% | $37.7M 3.9% | $36.8M 4.3% | $37.9M 4.3% | $38.0M 4.3% | $29.8M 3.4% | $32.1M 3.8% | $33.2M 3.5% |
| Total Operating Expenses | $118.8M 10.7% | $129.0M 12.1% | $121.4M 12.1% | $112.2M 11.7% | $99.8M 11.6% | $97.2M 11.0% | $99.7M 11.4% | $82.7M 9.3% | $81.4M 9.6% | $84.3M 8.9% |
| Operating Income | $84.7M 7.7% | $85.2M 8.0% | $90.2M 9.0% | $87.4M 9.1% | $85.2M 9.9% | $78.5M 8.9% | $58.5M 6.7% | $56.2M 6.3% | $60.5M 7.1% | $53.2M 5.6% |
| Interest Expense | $3.6M 0.3% | $2.5M 0.2% | $2.2M 0.2% | $1.9M 0.2% | $1.4M 0.2% | $2.0M 0.2% | $3.1M 0.3% | $3.5M 0.4% | $2.9M 0.3% | $3.5M 0.4% |
| Other Income (Expense), net | -$6.8M -0.6% | -$5.3M -0.5% | -$4.9M -0.5% | -$5.7M -0.6% | -$5.4M -0.6% | -$5.8M -0.7% | -$6.1M -0.7% | -$6.8M -0.8% | -$6.3M -0.7% | -$6.7M -0.7% |
| Pretax Income | $77.9M 7.0% | $79.9M 7.5% | $85.3M 8.5% | $81.7M 8.5% | $79.8M 9.3% | $72.7M 8.3% | $52.4M 6.0% | $49.4M 5.6% | $54.1M 6.4% | $46.5M 4.9% |
| Income Tax Expense | $18.9M 1.7% | $19.7M 1.8% | $22.5M 2.3% | $19.9M 2.1% | $20.1M 2.3% | $18.6M 2.1% | $13.0M 1.5% | $16.9M 1.9% | $18.0M 2.1% | $16.1M 1.7% |
| Net Income | $58.9M 5.3% | $60.2M 5.6% | $62.9M 6.3% | $61.8M 6.5% | $59.7M 7.0% | $54.1M 6.1% | $39.5M 4.5% | $32.5M 3.7% | $36.1M 4.3% | $30.4M 3.2% |
| Per Share | ||||||||||
| EPS (Basic) | $5.06 | $5.19 | $5.43 | $5.36 | $5.19 | $4.72 | $3.45 | $2.86 | $3.19 | $2.71 |
| EPS (Diluted) | $5.03 | $5.15 | $5.40 | $5.33 | $5.17 | $4.69 | $3.43 | $2.84 | $3.17 | $2.68 |
| Weighted Avg Shares (Basic) | 11.7M | 11.6M | 11.6M | 11.5M | 11.5M | 11.5M | 11.4M | 11.4M | 11.3M | 11.2M |
| Weighted Avg Shares (Diluted) | 11.7M | 11.7M | 11.6M | 11.6M | 11.6M | 11.5M | 11.5M | 11.4M | 11.4M | 11.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| JBSS | $786M | 13.4× | 7.2× | 0.7× | 3.8% | 18.4% | 5.3% | 16.3% | 15.7% | 0.1× | 206 |
Peers = companies sharing JBSS's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.